drugset / Trial / NCT05042908
Evaluation of LBL-003 Phase I Study in Patients With Advanced Malignancies
Phase 1
Completed
18 enrolled
Nanjing Leads Biolabs Co.,Ltd
Henan Cancer Hospital · collabHunan Cancer Hospital · collabShandong Cancer Hospital and Institute · collab
NaSingle-groupOpen-labelTreatment
Summary
This study is a single-arm, dose-escalation phase I clinical trial to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of LBL-003 injection in patients with advanced malignant tumors.
Timeline
- Start
- 2021-12-02
- Primary completion
- 2023-04-10
- Completion
- 2023-04-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LBL-003 | Unknown | — | — |